methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate | CAS:900186-90-5

We serve methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate CAS:900186-90-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate

Chemical Name:methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate
CAS.NO:900186-90-5
Synonyms:methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate
 
Physical and Chemical Properties:
Molecular Formula C10H13NO4
Molecular Weight 211.21500
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Vorapaxar Sulfate(CAS:705260-08-8).



Contact us for information like methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate Use and application,methyl (E)-3-(5-nitrocyclohex-1-en-1-yl)acrylate technical grade,usp/ep/jp grade.


Related News: The videos have gone viral on Chinese social media and have been praised as a novel way to raise awareness of the disease.1H-Pyrazole-1-carboxamidine hydrochloride manufacturer Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.Vitamin E Acetate supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.2-Chloropropionic acid vendor Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.